Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more
Labiana Health S.A. (LAB) - Net Assets
Latest net assets as of December 2022: €7.74 Million EUR
Based on the latest financial reports, Labiana Health S.A. (LAB) has net assets worth €7.74 Million EUR as of December 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€60.78 Million) and total liabilities (€53.04 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €7.74 Million |
| % of Total Assets | 12.74% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Labiana Health S.A. - Net Assets Trend (2022–2022)
This chart illustrates how Labiana Health S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Labiana Health S.A. (2022–2022)
The table below shows the annual net assets of Labiana Health S.A. from 2022 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | €7.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Labiana Health S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €722.13K | 9.33% |
| Other Components | €8.61 Million | 111.22% |
| Total Equity | €7.74 Million | 100.00% |
Labiana Health S.A. Competitors by Market Cap
The table below lists competitors of Labiana Health S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Goldspot Discoveries Corp
OTCQX:SPOFF
|
$11.19 Million |
|
GFM Services Bhd
KLSE:0039
|
$11.19 Million |
|
LITIUM AB SK1
F:5TW
|
$11.19 Million |
|
Opus One Resources Inc
V:OOR
|
$11.19 Million |
|
Legacy Minerals Holdings Ltd
AU:LGM
|
$11.19 Million |
|
BROADPEAK S.A. EO -02
F:J73
|
$11.19 Million |
|
Jooyontech
KO:044380
|
$11.18 Million |
|
STXYF
PINK:STXYF
|
$11.18 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Labiana Health S.A.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Labiana Health S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.81x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | €1.08 | €5.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Labiana Health S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -115.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15.46%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 7.85x
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -115.49% | -15.46% | 0.95x | 7.85x | €-9.72 Million |
Industry Comparison
This section compares Labiana Health S.A.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $121,255,116
- Average return on equity (ROE) among peers: 16.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Labiana Health S.A. (LAB) | €7.74 Million | -115.49% | 6.85x | $11.19 Million |
| Faes Farma SA (FAE) | $197.81 Million | 11.43% | 0.44x | $1.04 Billion |
| Laboratorio Reig Jofre S.A (RJF) | $44.70 Million | 21.23% | 0.96x | $57.17 Million |